Last reviewed · How we verify
Skin and Skin Structure Infections
Approved treatments
- Test formulation (Treatment A) · Pfizer
- Piperacillin And Tazobactam · Pfizer
Piperacillin and tazobactam is an antibacterial drug combining a penicillin with a beta-lactamase inhibitor. - CEPHALEXIN
Cephalexin is a cephalosporin antibacterial drug.
Clinical guidelines
- FDA label — 1L
Ceftriaxone is indicated for the treatment of skin and skin structure infections caused by susceptible organisms.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Skin and Skin Structure Infections patent landscape — cliff calendar, originator estates, attackable patents
- Skin and Skin Structure Infections treatment landscape brief
- Skin and Skin Structure Infections treatment updates RSS
Frequently asked questions about Skin and Skin Structure Infections
What drugs treat Skin and Skin Structure Infections?
Tracked treatments include Test formulation (Treatment A), Piperacillin And Tazobactam, CEPHALEXIN.
What is the treatment for Skin and Skin Structure Infections?
Standard treatment for Skin and Skin Structure Infections includes Test formulation (Treatment A), Piperacillin And Tazobactam, CEPHALEXIN. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Skin and Skin Structure Infections?
FDA label publishes guidelines for Skin and Skin Structure Infections. 1 guideline references tracked.
Related
- Treatment landscape: Skin and Skin Structure Infections patent cliff · Skin and Skin Structure Infections CI report
- Treatment: Test formulation (Treatment A) · Pfizer
- Treatment: Piperacillin And Tazobactam · Pfizer
- Treatment: CEPHALEXIN
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing